Related Experiment Video

Updated: Jul 15, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Congestive heart failure. A new milestone for a better life

S Agati1, E Vitali, M E DeBakey

  • 1A. De Gasperis Department, Niguarda Cà Granda Hospital, Milan, Italy. sasha.agati@tiscalinet.it

Minerva Cardioangiologica
|June 5, 2003
PubMed

Insights

Congestive heart failure (CHF) is a leading cause of death. Ventricular assist devices (VADs) offer crucial mechanical circulatory support for patients awaiting cardiac transplantation (CT), especially when donor organs are scarce.

Area of Science:

  • Cardiology
  • Medical Devices
  • Surgical Technology

Background:

  • Congestive heart failure (CHF) is a primary global cause of mortality, posing significant challenges despite medical advancements.
  • Cardiac transplantation (CT) is the optimal treatment for severe CHF, but organ scarcity limits its application.
  • Ventricular assist devices (VADs) are vital for managing acute hemodynamic deterioration and as a bridge to CT.

Purpose of the Study:

  • To evaluate the middle and long-term performance of the MicroMed DeBakey axial-flow VAD.
  • To analyze worldwide and Italian clinical experience with this VAD in patients bridged to cardiac transplantation.

Main Methods:

  • Retrospective analysis of clinical data from patients receiving the MicroMed DeBakey VAD.
  • Focus on pump performance metrics during the bridge to cardiac transplantation period.

Main Results:

  • The MicroMed DeBakey VAD demonstrated significant pump performance in supporting patients.
  • Data from worldwide and Italian centers highlight the device's role in bridging patients to CT.

Conclusions:

  • The MicroMed DeBakey VAD is an effective option for long-term mechanical circulatory support.
  • This device plays a critical role in the management of severe CHF patients awaiting cardiac transplantation.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...